|
Stereotaxis, Inc. (STXS) DCF -Bewertung
US | Healthcare | Medical - Instruments & Supplies | AMEX
|
- ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
- ✓ Professional Design: Trusted, Industry-Standard Templates
- ✓ Pre-Built For Quick And Efficient Use
- ✓ No Expertise Is Needed; Easy To Follow
Stereotaxis, Inc. (STXS) Bundle
Erforschen Sie die finanziellen Aussichten von Stereotaxis, Inc. (STXS) mit unserem benutzerfreundlichen DCF-Taschenrechner! Geben Sie Ihre Annahmen in Bezug auf Wachstum, Margen und Kosten ein, um den inneren Wert von Stereotaxis, Inc. (STXS) zu berechnen und Ihre Anlagestrategie zu verbessern.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 28.9 | 26.6 | 35.0 | 28.1 | 26.8 | 26.7 | 26.7 | 26.6 | 26.5 | 26.5 |
| Revenue Growth, % | 0 | -7.86 | 31.51 | -19.63 | -4.89 | -0.21758 | -0.21758 | -0.21758 | -0.21758 | -0.21758 |
| EBITDA | -4.7 | -6.6 | -12.8 | -18.3 | -21.2 | -11.9 | -11.8 | -11.8 | -11.8 | -11.8 |
| EBITDA, % | -16.28 | -24.74 | -36.5 | -65.18 | -79.35 | -44.41 | -44.41 | -44.41 | -44.41 | -44.41 |
| Depreciation | .1 | .1 | .1 | .5 | .6 | .3 | .3 | .3 | .3 | .3 |
| Depreciation, % | 0.42465 | 0.47394 | 0.30169 | 1.89 | 2.22 | 1.06 | 1.06 | 1.06 | 1.06 | 1.06 |
| EBIT | -4.8 | -6.7 | -12.9 | -18.9 | -21.8 | -12.1 | -12.1 | -12.1 | -12.1 | -12.0 |
| EBIT, % | -16.7 | -25.21 | -36.8 | -67.07 | -81.58 | -45.47 | -45.47 | -45.47 | -45.47 | -45.47 |
| Total Cash | 30.2 | 43.9 | 38.7 | 28.4 | 19.8 | 25.3 | 25.3 | 25.2 | 25.2 | 25.1 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | 5.3 | 3.5 | 5.4 | 5.1 | 3.8 | 4.2 | 4.2 | 4.2 | 4.2 | 4.2 |
| Account Receivables, % | 18.44 | 13.2 | 15.44 | 18.08 | 14.28 | 15.89 | 15.89 | 15.89 | 15.89 | 15.89 |
| Inventories | 1.8 | 3.3 | 4.4 | 7.9 | 8.4 | 4.9 | 4.8 | 4.8 | 4.8 | 4.8 |
| Inventories, % | 6.39 | 12.37 | 12.66 | 27.98 | 31.47 | 18.18 | 18.18 | 18.18 | 18.18 | 18.18 |
| Accounts Payable | 2.1 | 1.6 | 4.2 | 3.3 | 3.2 | 2.6 | 2.6 | 2.6 | 2.6 | 2.6 |
| Accounts Payable, % | 7.26 | 6.04 | 11.96 | 11.62 | 11.92 | 9.76 | 9.76 | 9.76 | 9.76 | 9.76 |
| Capital Expenditure | .0 | -.1 | -1.4 | -2.4 | -.4 | -.8 | -.8 | -.8 | -.8 | -.8 |
| Capital Expenditure, % | -0.10202 | -0.26623 | -3.99 | -8.45 | -1.37 | -2.83 | -2.83 | -2.83 | -2.83 | -2.83 |
| Tax Rate, % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EBITAT | -4.5 | -6.5 | -10.1 | -19.8 | -21.8 | -11.4 | -11.3 | -11.3 | -11.3 | -11.3 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -9.4 | -6.6 | -11.9 | -25.7 | -21.0 | -9.3 | -11.8 | -11.8 | -11.8 | -11.7 |
| WACC, % | 11.03 | 11.04 | 11.01 | 11.04 | 11.04 | 11.03 | 11.03 | 11.03 | 11.03 | 11.03 |
| PV UFCF | ||||||||||
| SUM PV UFCF | -41.2 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | -12 | |||||||||
| Terminal Value | -132 | |||||||||
| Present Terminal Value | -78 | |||||||||
| Enterprise Value | -120 | |||||||||
| Net Debt | -14 | |||||||||
| Equity Value | -105 | |||||||||
| Diluted Shares Outstanding, MM | 81 | |||||||||
| Equity Value Per Share | -1.31 |
What You Will Get
- Real Stereotaxis Data: Preloaded financials – from revenue to EBIT – based on actual and projected figures.
- Full Customization: Adjust all critical parameters (yellow cells) like WACC, growth %, and tax rates.
- Instant Valuation Updates: Automatic recalculations to analyze the impact of changes on Stereotaxis’s fair value.
- Versatile Excel Template: Tailored for quick edits, scenario testing, and detailed projections.
- Time-Saving and Accurate: Skip building models from scratch while maintaining precision and flexibility.
Key Features
- Comprehensive DCF Calculator: Features detailed unlevered and levered DCF valuation models tailored for Stereotaxis, Inc. (STXS).
- WACC Calculator: Pre-configured Weighted Average Cost of Capital sheet with adjustable inputs specific to Stereotaxis, Inc. (STXS).
- Customizable Forecast Assumptions: Adjust growth rates, capital expenditures, and discount rates to fit Stereotaxis, Inc. (STXS) projections.
- Integrated Financial Ratios: Evaluate profitability, leverage, and efficiency ratios for Stereotaxis, Inc. (STXS).
- Interactive Dashboard and Charts: Visual representations summarize essential valuation metrics for straightforward analysis of Stereotaxis, Inc. (STXS).
How It Works
- 1. Download the Template: Obtain and open the Excel file containing Stereotaxis, Inc.'s preloaded data.
- 2. Adjust Assumptions: Modify essential inputs such as growth rates, WACC, and capital expenditures.
- 3. View Results in Real-Time: The DCF model automatically computes intrinsic value and NPV.
- 4. Explore Scenarios: Evaluate various forecasts to assess different valuation results.
- 5. Present with Assurance: Share professional valuation insights to guide your strategic decisions.
Why Choose This Calculator for Stereotaxis, Inc. (STXS)?
- Comprehensive Tool: Features DCF, WACC, and financial ratio analyses tailored for Stereotaxis, Inc. (STXS).
- Customizable Inputs: Modify yellow-highlighted cells to explore different scenarios for Stereotaxis, Inc. (STXS).
- Detailed Insights: Automatically computes Stereotaxis, Inc. (STXS)'s intrinsic value and Net Present Value.
- Preloaded Data: Includes historical and forecasted data for Stereotaxis, Inc. (STXS) to provide precise starting points.
- Professional Quality: Perfect for financial analysts, investors, and business consultants focusing on Stereotaxis, Inc. (STXS).
Who Should Use Stereotaxis, Inc. (STXS)?
- Healthcare Professionals: Enhance patient care with advanced robotic solutions for cardiac procedures.
- Medical Researchers: Utilize cutting-edge technology to conduct innovative studies in electrophysiology.
- Hospital Administrators: Streamline operational efficiency by integrating state-of-the-art systems into existing workflows.
- Investors: Assess growth potential and market trends with comprehensive data on the medical robotics sector.
- Students and Educators: Explore the intersection of technology and medicine through hands-on learning experiences.
What the Template Contains
- Comprehensive DCF Model: Editable template featuring detailed valuation calculations tailored for Stereotaxis, Inc. (STXS).
- Real-World Data: Stereotaxis's historical and projected financials preloaded for in-depth analysis.
- Customizable Parameters: Adjust WACC, growth rates, and tax assumptions to explore various scenarios.
- Financial Statements: Complete annual and quarterly breakdowns for enhanced insights into Stereotaxis, Inc. (STXS).
- Key Ratios: Integrated analysis for profitability, efficiency, and leverage metrics.
- Dashboard with Visual Outputs: Charts and tables providing clear, actionable results specific to Stereotaxis, Inc. (STXS).
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.